Spinal Cord Diseases D013118

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Spinal Cord Diseases

Description

Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.   MeSH

Subtype Terms (13)

Amyotrophic Lateral Sclerosis
242 drugs (108 approved, 134 experimental)

Muscular Atrophy, Spinal
32 drugs (19 approved, 13 experimental)

Myelitis
5 drugs (4 approved, 1 experimental)

Pneumorrhachis
 

Spinal Cord Compression
6 drugs (3 approved, 3 experimental)

Spinal Cord Injuries
196 drugs (103 approved, 93 experimental)

Spinal Cord Neoplasms
16 drugs (11 approved, 5 experimental)

Spinal Cord Vascular Diseases
 

Spinocerebellar Degenerations
5 drugs (2 approved, 3 experimental)

Stiff-Person Syndrome
14 drugs (12 approved, 2 experimental)


Phase 1 Indicated Drugs (1)


Organization Involved with Phase 1 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.